Thursday, December 3, 2015

Cancer Treatment Centers of America® earns Top Hospital Award

For the first time, The Leapfrog Group has named Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) to its annual list of Top Hospitals. This recognition showcases the hospital's commitment to providing safe, efficient and high quality patient care.  Out of the 1,600 hospitals that reported information to The Leapfrog Group, CTCA at Midwestern was one of only 98 to receive the honor of being named a Top Hospital. On November 27, 2015 CTCA at Midwestern opened a 168,078 square-foot, six-story inpatient tower to better serve patients from around the country and internationally. The new tower offers 72 innovative, single-occupancy inpatient oncology rooms, and common space designed to bring comfort and convenience to patients and their loved ones. When designing the tower, the same elements that made CTCA at Midwestern a Top Hospital were considered of utmost importance, including superior patient care, safety and efficiency. Only six percent of hospitals eligible receive the Top Hospital award, which is given to urban, rural and children's hospitals that publicly report their performance through the annual Leapfrog Hospital Survey and meet the high standards defined in each year's Top Hospitals Methodology. The selection is based on the results of the survey, which measures hospitals' performance on patient safety and quality, focusing on three critical areas of hospital care: how patients fare, resource use and management structures established to prevent errors. Performance across many areas of hospital care is considered in establishing the qualifications for the award, including survival rates for high-risk procedures and a hospital's ability to prevent medication errors.
CTCA serves patients from around the world at its hospitals in Atlanta, Suburban Chicago, Philadelphia, Phoenix and Tulsa. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.

No comments:

Post a Comment